GlassScriptPhysician profile
David N Pederson
NPI 1700857471
$45,640.42
in general payments reported to CMS, 2019-2025
25 companies · $5,131 in 2025
The $5,131 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $3,229 · 2021: $2,974 · 2022: $5,171 · 2023: $5,609 · 2024: $5,028 · 2025: $5,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,502 · Travel and Lodging: $4,767 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,502.10 |
| Travel and Lodging | $4,766.52 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11,533.32 | 2019-2024 | Xarelto |
| Medtronic, INC. | $8,699.53 | 2021-2025 | Pulseselect, Affera Mapping System, Micra |
| Abbott Laboratories | $6,266.90 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Boston Scientific Corporation | $6,001.95 | 2019-2025 | General - Therapies, Watchman Flx, Farapulse |
| Acutus Medical, INC. | $4,588.04 | 2021-2023 | |
| Medtronic Vascular, INC. | $3,675.87 | 2019-2020 | |
| Atricure, INC. | $1,664.79 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $1,581.34 | 2019-2025 | Carto 3 |
| Biotronik INC. | $507.27 | 2019-2025 | Amvia Edge, Renamic Neo, Acticor 7 Vr-T Dx |
| Pfizer INC. | $295.63 | 2021-2025 | |
| Cordis US Corp. | $168.17 | 2025 | Mynx Control Venous |
| Cardiva Medical, INC. | $152.60 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biosig Technologies, INC. | $144.80 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $56.29 | 2024-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $45.66 | 2021-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $43.16 | 2023-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.56 | 2019-2024 | Lifevest |
| Braemar Manufacturing, LLC | $32.82 | 2019 | |
| Alnylam Pharmaceuticals INC. | $28.86 | 2025 | Amvuttra |
| Itamar Medical INC | $28.27 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $24.12 | 2022 | |
| Elutia, INC. | $18.47 | 2019 | |
| Cook Medical LLC | $16.50 | 2020 | |
| Preventice Services, LLC | $13.92 | 2021 | |
| Medtronic USA, INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pederson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.